XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.2
Note 11 - Stock-Based Compensation
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Shareholders' Equity and Share-Based Payments [Text Block]

11.

Stock-Based Compensation

 

Stock-based compensation expense for the three and six months ended June 30, 2025 and 2024 was allocated as follows:

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 

(in thousands)

 

2025

   

2024

   

2025

   

2024

 

Cost of revenues

  $ 31     $ 66     $ 61     $ 118  

Sales and marketing expenses

    106       159       224       289  

General and administrative expenses

    240       927       599       1,698  

Research and development expenses

    95       126       188       221  

Total stock-based compensation

  $ 472     $ 1,278     $ 1,072     $ 2,326  

 

As of June 30, 2025, the total compensation costs related to unvested awards not yet recognized was $2.2 million and the weighted average period over which it is expected to be recognized is approximately 1.4 years. The Company did not capitalize any stock-based compensation.

 

Restricted stock unit (“RSU”) activity for the six months ended June 30, 2025 was as follows:

 

                   

Market-

           

Performance-

         
   

Time-Based

           

Based

           

Based

         
   

Restricted

   

Grant Date

   

Restricted

   

Grant Date

   

Restricted

   

Grant Date

 
   

Stock Units

   

Fair Value

   

Stock Units

   

Fair Value

   

Stock Units

   

Fair Value

 

Balance at December 31, 2024

    1,378,995     $ 3.51       558,958     $ 2.61       375,895     $ 4.19  

Granted

    297,821       0.36       -       -       -       -  

Vested

    (442,448 )     3.71       -       -       -       -  

Forfeited

    (180,817 )     3.47       (126,437 )     2.61       (98,449 )     4.19  

Balance at June 30, 2025

    1,053,551     $ 2.55       432,521     $ 2.61       277,446     $ 4.19  

 

The aggregate fair value of RSUs that vested during the six months ended June 30, 2025, and 2024 was $0.2 million and $0.5 million, respectively. Unvested shares related to market-based and performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Actual vesting could range from zero to 150% of their target amounts.

 

Performance-based RSU awards are contingent on the achievement of certain performance metrics. Compensation cost associated with performance-based RSUs are recognized based on the estimated number of shares that the Company ultimately expects will be earned. If the estimated number of shares to be earned is revised in the future, then stock-based compensation expense will be adjusted accordingly.

 

Stock option activity for the six months ended June 30, 2025 was as follows:

 

   

Number of Options

   

Weighted-Average Exercise Price

   

Weighted-Average Remaining Contractual Term

   

Aggregate Intrinsic Value (in thousands)

 

Outstanding and exercisable at December 31, 2024

    827,458     $ 3.24                  

Cancelled/Forfeited

    (118,665 )     5.06                  

Outstanding and exercisable at June 30, 2025

    708,793     $ 2.94       2.5     $ -  

 

There is no aggregate intrinsic value at June 30, 2025 because the Company’s closing stock price of $0.44 is below the exercise price of the outstanding options.